Aslan Pharmaceuticals Pte Ltd.
Records under this name other than the patents Aslan Pharmaceuticals Pte Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Back to Aslan Pharmaceuticals Pte Ltd.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,382,903 | Cancer Therapy Lapsed on the fee record Ended Jul 12, 2026 · High confidence | Lapsed on the fee record | Ended Jul 12, 2026 | High confidence |
| US 11,311,548 | Cancer Therapy Lapsed on the fee record Ended Apr 26, 2026 · High confidence | Lapsed on the fee record | Ended Apr 26, 2026 | High confidence |
| US 10,849,899 | Combination Therapy Comprising Varlitinib and an Anticancer Agent Lapsed on the fee record Ended Dec 1, 2024 · High confidence | Lapsed on the fee record | Ended Dec 1, 2024 | High confidence |
| 15/757,166 | Treatment of Biliary Duct Cancer Abandoned Abandoned Oct 13, 2019 | Abandoned | Abandoned Oct 13, 2019 | |
| 16/094,199 | Method of Treating Liver Cancer Abandoned Abandoned Jul 22, 2020 | Abandoned | Abandoned Jul 22, 2020 | |
| 16/134,736 | Treatment of Biliary Duct Cancer Abandoned Abandoned Feb 14, 2020 | Abandoned | Abandoned Feb 14, 2020 | |
| 16/312,816 | Maintenance Therapy for the Treatment of Cancer Abandoned Abandoned Sep 12, 2020 | Abandoned | Abandoned Sep 12, 2020 | |
| 16/625,902 | Method of Treatment for Cutaneous T Cell Lymphoma Using IL-13R Antibody held by Aslan Pharmaceuticals Pte. Ltd. and CSL Limited Abandoned Abandoned Feb 11, 2022 | Abandoned | Abandoned Feb 11, 2022 | |
| 17/272,243 | Treatment Employing ANTI-IL-13R Antibody or Binding Fragment Thereof now held by Vellera Therapeutics, Inc. Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 17/283,724 | Malonate Salt of Varlitinib Abandoned Abandoned Aug 5, 2024 | Abandoned | Abandoned Aug 5, 2024 |